Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Completed 22Recruiting 16Terminated 9Unknown 8Active not recruiting 3Enrolling by invitation 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Endocrine 3Other hematologic neoplasm 1NET 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 52Thyroid Neoplasms 19Thyroid Cancer, Papillary 16Carcinoma, Neuroendocrine 16Pheochromocytoma 11Adrenocortical Carcinoma 11Thyroid Carcinoma, Anaplastic 10Gastro-enteropancreatic neuroendocrine tumor 10Small Cell Lung Carcinoma 9Paraganglioma 9Multiple Endocrine Neoplasia Type 1 9Pituitary Neoplasms 8Lung Neoplasms 8Adenoma, Islet Cell 8Sarcoma 7Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Medullary 6Adenocarcinoma, Follicular 6Colorectal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Merkel Cell 5Carcinoid Tumor 5Somatostatinoma 4Pancreatic Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Cholangiocarcinoma 4Carcinoma, Hepatocellular 4

Interventions

Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Adrenal Gland Neoplasms × Endocrine × Clear all
NCT00568139 2026-05-07

Evaluation of Side Effects of Mitotane

University of Wuerzburg

Active not recruiting
400 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT04459273 2026-02-05

FAPI PET RDRC

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
26 enrolled
CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther hematologic neoplasm

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Unknown Primary, Skin Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Hematologic Neoplasms

NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Changi General Hospital

Phase 2/3 Active not recruiting
100 enrolled
Endocrine

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡